GENE ONLINE|News &
Opinion
Blog

Drug Development
Trials & Approvals AstraZenca
AstraZeneca Calls Off Monalizumab Study With Innate After Phase 3 Disappoints
2022-08-02
Licensing Sosei Heptares
Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
Licensing IONIS-FB-LRx
Roche Receives Rights to Ionis’ Antisense Kidney Disease Drug for $55 Million
2022-07-12
R&D Alzheimer's Disease
Are Memory Loss in Alzheimer’s Disease Related to Changes in Blood Vessels in the Brain?
2022-07-07
Technology Drug Development
CYTENA BPS and Leadgene Bio to Level Up Taiwan’s Protein Drugs Production
2022-06-05Partner
Asia-Pacific AI
Israeli and South Korean Companies Collaborate in Drug Innovation with Data Platform
2022-04-19
Special 2022 psychedelics
WSJ Health Forum 2022: Psychedelics Set to Take Center Stage in Mental Wellness
2022-03-24
Innovation Alzheimer's Disease
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
Asia-Pacific
Korea’s First Private-Led New Drug Cluster to Launch in Late September
2021-09-11
VIRTUALMAN Breaking Barriers in Drug Development with AI Solutions
2021-08-05Partner
AI Technology Revamping Drug Development! VIRTUALMAN to Demonstrate Powerful Solutions in BIO Asia-Taiwan 2021
2021-07-15Partner
Funding Drug Development
Genesis Bags $52M Series A to Employ AI for Drug Discovery and Development
2020-12-06
COVID-19 Japan
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
Trials & Approvals Anti-HIV
Kainos Medicine’s New HIV Drug Kicks Off Phase III Trial in China
2020-03-05
Trials & Approvals AI
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
LATEST
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
READ MORE
EVENT
2023-03-28
Reuters Events: Pharma USA 2023
Philadelphia, USA
2023-04-24
Cell & Gene Therapy Summit 2023
Brussels, Belgium
2023-04-28
Boston Chinese Investment Club 2023 Biotech Pitch Competition
Boston, USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top